{"id":"https://openalex.org/W2586050985","doi":"https://doi.org/10.1177/0961203317692433","title":"Failure of a systemic lupus erythematosus response index developed from clinical trial data: lessons examined and learned","display_name":"Failure of a systemic lupus erythematosus response index developed from clinical trial data: lessons examined and learned","publication_year":2017,"publication_date":"2017-02-07","ids":{"openalex":"https://openalex.org/W2586050985","doi":"https://doi.org/10.1177/0961203317692433","mag":"2586050985","pmid":"https://pubmed.ncbi.nlm.nih.gov/28173737"},"language":"en","primary_location":{"id":"doi:10.1177/0961203317692433","doi":"https://doi.org/10.1177/0961203317692433","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0961203317692433","pdf_url":null,"source":{"id":"https://openalex.org/S115920904","display_name":"Lupus","issn_l":"0961-2033","issn":["0961-2033","1477-0962"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lupus","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076667256","display_name":"Lindsy J. Forbess","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"L J Forbess","raw_affiliation_strings":["Cedars-Sinai Medical Center, Division of Rheumatology, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cedars-Sinai Medical Center, Division of Rheumatology, USA","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013195713","display_name":"Catherine J. Bresee","orcid":"https://orcid.org/0000-0002-5710-4906","observed_orcids":["https://orcid.org/0000-0002-5710-4906"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C Bresee","raw_affiliation_strings":["Cedars-Sinai Medical Center, Department of Biostatistics and Bioinformatics, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cedars-Sinai Medical Center, Department of Biostatistics and Bioinformatics, USA","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071430304","display_name":"Daniel J. Wallace","orcid":"https://orcid.org/0000-0002-2502-1372","observed_orcids":["https://orcid.org/0000-0002-2502-1372"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D J Wallace","raw_affiliation_strings":["Cedars-Sinai Medical Center, Division of Rheumatology, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cedars-Sinai Medical Center, Division of Rheumatology, USA","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030335777","display_name":"Michael H. Weisman","orcid":"https://orcid.org/0000-0001-5568-388X","observed_orcids":["https://orcid.org/0000-0001-5568-388X"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M H Weisman","raw_affiliation_strings":["Cedars-Sinai Medical Center, Division of Rheumatology, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cedars-Sinai Medical Center, Division of Rheumatology, USA","institution_ids":["https://openalex.org/I1282927834"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5076667256"],"corresponding_institution_ids":["https://openalex.org/I1282927834"],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":1.195,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.76715583,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"26","issue":"9","first_page":"909","last_page":"916"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/systemic-lupus-erythematosus","display_name":"systemic lupus erythematosus","score":1.0},{"id":"https://openalex.org/keywords/belimumab","display_name":"belimumab","score":0.8790000081062317},{"id":"https://openalex.org/keywords/response-index","display_name":"response index","score":0.5040000081062317},{"id":"https://openalex.org/keywords/real-world-data","display_name":"real-world data","score":0.6930000185966492},{"id":"https://openalex.org/keywords/model-validation","display_name":"model validation","score":0.5690000057220459},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.5509999990463257},{"id":"https://openalex.org/keywords/disease-heterogeneity","display_name":"disease heterogeneity","score":0.7170000076293945},{"id":"https://openalex.org/keywords/outcome-measures","display_name":"outcome measures","score":0.45899999141693115},{"id":"https://openalex.org/keywords/anti-dsdna-antibodies","display_name":"anti-dsDNA antibodies","score":0.6759999990463257},{"id":"https://openalex.org/keywords/complement-c3-and-c4","display_name":"complement C3 and C4","score":0.7609999775886536},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.7860000133514404},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.5130000114440918},{"id":"https://openalex.org/keywords/physician-s-global-assessment","display_name":"physician global assessment","score":0.6499999761581421}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9375124573707581},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7249585390090942},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7229795455932617},{"id":"https://openalex.org/C2781205201","wikidata":"https://www.wikidata.org/wiki/Q1996249","display_name":"Belimumab","level":5,"score":0.6890063285827637},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.5864529609680176},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.5860981345176697},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5283176302909851},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.49696972966194153},{"id":"https://openalex.org/C199475168","wikidata":"https://www.wikidata.org/wiki/Q1539689","display_name":"MedDRA","level":4,"score":0.4478934705257416},{"id":"https://openalex.org/C65409693","wikidata":"https://www.wikidata.org/wiki/Q425265","display_name":"Statistical significance","level":2,"score":0.4438548982143402},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.42429599165916443},{"id":"https://openalex.org/C2776912625","wikidata":"https://www.wikidata.org/wiki/Q1485","display_name":"Systemic lupus erythematosus","level":3,"score":0.4143819808959961},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.23697170615196228},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.21872541308403015},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.12750953435897827},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.1264212429523468},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.08629021048545837},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.07520937919616699},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.07043871283531189},{"id":"https://openalex.org/C170286685","wikidata":"https://www.wikidata.org/wiki/Q409346","display_name":"B-cell activating factor","level":4,"score":0.0},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000076162","descriptor_name":"Therapeutic Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000974","descriptor_name":"Antibodies, Antinuclear","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002097","descriptor_name":"C-Reactive Protein","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D003176","descriptor_name":"Complement C3","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D003181","descriptor_name":"Complement C4","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008180","descriptor_name":"Lupus Erythematosus, Systemic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008180","descriptor_name":"Lupus Erythematosus, Systemic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008180","descriptor_name":"Lupus Erythematosus, Systemic","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011507","descriptor_name":"Proteinuria","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015990","descriptor_name":"Placebo Effect","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017063","descriptor_name":"Outcome Assessment, Health Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057566","descriptor_name":"Self Report","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D066264","descriptor_name":"Datasets as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/0961203317692433","doi":"https://doi.org/10.1177/0961203317692433","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0961203317692433","pdf_url":null,"source":{"id":"https://openalex.org/S115920904","display_name":"Lupus","issn_l":"0961-2033","issn":["0961-2033","1477-0962"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lupus","raw_type":"journal-article"},{"id":"pmid:28173737","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28173737","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lupus","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1967992422","https://openalex.org/W2009414853","https://openalex.org/W2018360946","https://openalex.org/W2024720316","https://openalex.org/W2033299724","https://openalex.org/W2046330020","https://openalex.org/W2048462515","https://openalex.org/W2061494520","https://openalex.org/W2085579205","https://openalex.org/W2091468965","https://openalex.org/W2097165105","https://openalex.org/W2106574491","https://openalex.org/W2107216509","https://openalex.org/W2111416025","https://openalex.org/W2129925362","https://openalex.org/W2131457901","https://openalex.org/W2131469748","https://openalex.org/W2136149088","https://openalex.org/W2141455950","https://openalex.org/W2143358047","https://openalex.org/W2154666854","https://openalex.org/W2168146874","https://openalex.org/W2170524712","https://openalex.org/W2206541367","https://openalex.org/W2327627445","https://openalex.org/W4298222310"],"related_works":["https://openalex.org/W1976199411","https://openalex.org/W2796543417","https://openalex.org/W2091468965","https://openalex.org/W3211374154","https://openalex.org/W4291179447","https://openalex.org/W2156321834","https://openalex.org/W2035732188","https://openalex.org/W4391918133","https://openalex.org/W4297316436","https://openalex.org/W4399483655"],"abstract_inverted_index":{"Background":[0],"Our":[1],"primary":[2],"goal":[3],"was":[4,107,111,212],"to":[5,13,113,121,267,289],"create":[6],"an":[7,176,187],"outcome":[8,263,292],"change":[9],"score":[10],"index":[11,120,225],"similar":[12],"a":[14,37,68],"standard":[15],"rheumatoid":[16],"arthritis":[17],"(RA)":[18],"model":[19],"utilizing":[20],"real-world":[21],"data":[22,47,132,229],"in":[23,67,160,186,205,237],"systemic":[24],"lupus":[25],"erythematosus":[26],"(SLE)":[27],"patients":[28,71,98,173,182],"that":[29,265],"occurred":[30],"during":[31],"their":[32],"phase":[33],"3":[34],"trials":[35,49],"with":[36,73,175],"Food":[38],"and":[39,72,96,151,171,262],"Drug":[40],"Administration-approved":[41],"drug.":[42],"Methods":[43],"We":[44,241],"utilized":[45],"raw":[46],"from":[48,87,227],"of":[50,55,70,94,104,117,128,162,179,196,250,252,274],"belimumab":[51,191],"for":[52,81,133,190,254],"the":[53,102,115,118,155,166,206,209,238,248,272,275],"treatment":[54,123],"SLE.":[56],"Data":[57],"were":[58,76,79,137],"split":[59],"80/20":[60],"into":[61],"training/validation":[62],"sets.":[63],"Index":[64],"variables":[65,136,164],"present":[66],"majority":[69],"face":[74],"validity":[75],"selected.":[77],"Variables":[78],"scored":[80],"each":[82],"patient":[83],"as":[84],"percentage":[85,93],"improvement":[86,159],"baseline":[88],"after":[89,101],"one":[90],"year.":[91],"The":[92,224,279],"placebo-":[95,170],"drug-treated":[97,172],"considered":[99],"improved":[100,180],"application":[103],"various":[105],"criteria":[106],"ascertained.":[108],"Logistic":[109],"regression":[110],"employed":[112],"determine":[114],"ability":[116],"new":[119],"predict":[122],"assignment.":[124],"Results":[125],"A":[126],"total":[127],"1693":[129],"subjects":[130],"had":[131],"analyses.":[134],"Eight":[135],"chosen:":[138],"arthritis,":[139],"rash,":[140],"physician":[141],"global":[142],"assessment,":[143],"fatigue,":[144],"anti-double":[145],"stranded":[146],"DNA":[147],"antibodies,":[148],"C3,":[149],"C4":[150],"C-reactive":[152],"protein.":[153],"In":[154],"training":[156,228],"dataset,":[157],"\u226520%":[158],"\u22654":[161],"eight":[163],"produced":[165],"largest":[167],"difference":[168],"between":[169],"(22.1%)":[174],"acceptable":[177],"rate":[178],"placebo-treated":[181],"(25%).":[183],"This":[184],"resulted":[185],"odds":[188,210],"ratio":[189,211],"(10":[192],"mg/kg)":[193],"vs":[194],"placebo":[195],"2.7":[197],"(95%":[198,217],"CI:":[199,218],"2.0-3.6;":[200],"p":[201,220],"<":[202],"0.001).":[203],"However,":[204],"validate":[207],"dataset":[208],"not":[213,231],"significant":[214],"at":[215],"1.3":[216],"0.8-2.2;":[219],"=":[221],"0.863).":[222],"Conclusions":[223],"created":[226],"did":[230],"achieve":[232],"statistical":[233],"significance":[234],"when":[235],"tested":[236],"validation":[239],"set.":[240],"have":[242],"speculated":[243],"why":[244],"this":[245],"happened.":[246],"Is":[247],"lack":[249],"success":[251],"therapeutics":[253],"SLE":[255,291],"caused":[256],"by":[257],"ineffective":[258],"medications,":[259],"study":[260],"design":[261],"instruments":[264],"fail":[266],"inform":[268],"us,":[269],"or":[270],"is":[271],"heterogeneity":[273],"disease":[276],"too":[277],"daunting?":[278],"lessons":[280],"learned":[281],"here":[282],"can":[283],"help":[284],"direct":[285],"future":[286],"endeavors":[287],"intended":[288],"improve":[290],"instruments.":[293]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-02-17T00:00:00"}